Having a parent with Alzheimer's does not mean you will get it, and the library's study records give no single risk figure for the children of people with the disease. What the studies show is that family history matters differently by type: in one Stockholm cohort aged 75 or older it was linked to higher risk only among APOE ε4 carriers, while in the rare autosomal dominant forms a parent's age at symptom onset helps predict when symptoms start.
What the studies found
Parental dementia is common. In the Rotterdam Study, 407 of 2,087 dementia-free participants (19.6%, mean age 64 years, 55% female) reported a history of dementia in either parent, with a mean age at diagnosis of 79 years. The study examined the link with dementia risk until 2015 after adjusting for demographics, cardiovascular risk factors and known genetic risk variants, but the library's record of it does not include the risk figures, so none are quoted here.
- Study
- Parental family history of dementia in relation to subclinical brain disease and dementia risk
A 2004 community cohort in the Kungsholmen district of Stockholm followed 907 nondemented people aged 75 years or older for 6 years. Subjects with at least 2 siblings with dementia were at increased risk of Alzheimer's, and individuals with both the APOE ε4 allele and at least 2 affected first-degree relatives had a higher risk of dementia and Alzheimer's. Among ε4 carriers, those with 2 or more first-degree demented relatives had increased risk, whereas no increased risk was detected among non-ε4 carriers.
- Study
- APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study
For context, dementia is common across the population whether or not a parent had it. A 2025 Nature Medicine analysis of a community cohort (n = 15,043) estimated the lifetime risk of dementia after age 55 at 42%, with lifetime risks from approximately 45% to 60% in women, Black adults and APOE ε4 carriers. An older Framingham analysis (1997) estimated the remaining lifetime risk of Alzheimer's at 6.3% for a 65-year-old man and 12% for a 65-year-old woman, using different methods and a different outcome.
- Studies
- Lifetime risk and projected burden of dementia
- Lifetime risk of dementia and Alzheimer's disease. The impact of mortality on risk estimates in the Framingham Study
The picture is different in the rare inherited forms. A 2014 systematic review and meta-analysis in Neurology assembled data on 387 autosomal dominant Alzheimer's pedigrees (3,275 individuals, 1,307 of them affected with known age at symptom onset). It found strong correlations between an individual's age at symptom onset and the value predicted from parental age at onset and mean ages at onset by mutation type and family, which persisted after controlling for APOE genotype and sex.
Family history is also common among people who have dementia, and is not a clean marker of a genetic cause. A 2025 study in Genetics in Medicine reported a positive family history in 42% of patients in the Alzheimer's cohort, 48% in the frontotemporal dementia cohort and 34% in other dementia types. Of 51 patients identified as high-risk, 38 had complete genetic data and 38% of those carried diagnostically significant variants.
A 2025 Neurology study followed 243 cognitively unimpaired adults with a parental history of Alzheimer's (follow-up 6.72 years on average) with amyloid and tau PET; 71 developed mild cognitive impairment. It reported sex and parent-of-origin differences in how amyloid and tau were related, and its summary describes no comparison group without a parental history.
What remains uncertain
The library holds no study record that states how much a parent's Alzheimer's raises a child's own risk as a single figure. The Rotterdam record names the question but its figures are not in the text the library holds, and the Stockholm cohort studied only very old people in one district.
- Studies
- Parental family history of dementia in relation to subclinical brain disease and dementia risk
- APOE genotype, family history of dementia, and Alzheimer disease risk: a 6-year follow-up study
Lifetime-risk estimates depend on the method and the era. The 2025 authors list limitations that include a single US cohort from four communities, dementia ascertainment methods that changed over decades, and a higher estimate than prior studies that partly reflects more complete case capture. Figures from different studies should not be set side by side as if they measured the same thing.
Most of these records cannot say what causes the family link: genes, shared environment, or both. Whether a particular family's history reflects a rare inherited form is a question for a clinician or genetic counsellor who knows the family.
This page describes what published studies in alzhub's library report. It is not medical advice and does not apply to any one person. Where a decision would follow, a clinician who knows the person is the one who can say what a result or a choice means for them.
Questions
- If my parent has Alzheimer's, am I certain to get it?
- No. In a Stockholm cohort of 907 people aged 75 years or older, a family history of dementia was associated with increased risk of dementia and Alzheimer's only among APOE ε4 carriers, and no increased risk was detected among non-ε4 carriers.
- Is there a rare form of Alzheimer's that runs in families?
- Yes: autosomal dominant Alzheimer's. A meta-analysis of 387 pedigrees found that age at symptom onset correlated strongly with predictions based on parental age at onset and mutation type.
- How common is a family history among people with dementia?
- In one 2025 study, a positive family history was reported in 42% of patients in the Alzheimer's cohort, 48% in the frontotemporal dementia cohort and 34% in other dementia types.
Read on
Last updated